
GMO x Mimosa #7
About
GMO x Mimosa #7 is a hybrid cannabis strain. Lab samples test between 15.8% and 21.4% THC, with caryophyllene (0.63%) as the dominant terpene.
Why does GMO x Mimosa #7 feel pain-relieving?
GMO x Mimosa #7's pain-relieving effects are linked to its dominant caryophyllene (0.63%), one of the few terpenes that binds directly to CB2 cannabinoid receptors. Complemented by limonene (0.53%), known for mood elevation and stress relief.
Strain Profile
May Help With
Caryophyllene has strong anti-inflammatory properties
Caryophyllene binds to CB2 receptors for pain relief
Linalool has calming, stress-relieving properties
Linalool is known for anti-anxiety effects
Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.
Similar Strains
Strains with a similar profile you might enjoy
Quick Info
- Type
- hybrid
- Breeder
- Not verified
- THC
- 15.8–21.4%
- Chemotype
- Caryophyllene-dominant
What is Caryophyllene?
Spicy, peppery terpene found in black pepper, cloves, and cinnamon.
Learn more →
← Back to all strainsAbout GMO x Mimosa #7
- GMO x Mimosa #7 is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
- GMO x Mimosa #7 typically tests at 15.8% to 21.4% THC.
- The dominant terpenes in GMO x Mimosa #7 are Caryophyllene, Limonene, Humulene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.
